Skip to content

Olema Pharmaceuticals, Inc. OLMA Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$679K+18.1%
Opko Health logo
Opko HealthOPK
-$6.97M-155%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.59M+192%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$1.06M+246%
Immunome logo
ImmunomeIMNM
$5.1M+199%
Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$973.05M+244%
Enterprise value$921.46M+295%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Reported directly by Olema Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets?
Olema Pharmaceuticals, Inc. (OLMA) reported increase (decrease) in prepaid expense and other assets of -$2.6M in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
Olema Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 373.0% year-over-year, from -$549K to -$2.6M.
What is the long-term trend for Olema Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets?
Over 3 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a 424.3% compound annual growth rate (CAGR), from $40K to $5.77M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.